Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eiji Takeuchi

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Thoracic Cancer|September 5, 2023
Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.
Thoracic Cancer|December 17, 2024
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Thoracic Cancer|December 13, 2023
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2022
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancerEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.
Circulation|January 29, 2014
Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer?Soji Nishio, Shinsaku Takeda, Kunihiko Kosuga, et al.
Circulation|January 21, 2015
Rare case of cardiac hemangioma causing massive pericardial effusion: can a left atrial tumor produce pericardial effusion?Soji Nishio, Kunihiko Kosuga, Senri Miwa, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 14, 2006
Histopathological findings of new in-stent lesions developed beyond five yearsKatsuyuki Hasegawa, Hideo Tamai, Eisho Kyo, et al.
Thoracic Cancer|September 17, 2023
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancerYohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, et al.
Modern Rheumatology|June 7, 2012
Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumabMie Fusama, Hideko Nakahara, Yoshimasa Hamano, et al.
Oncology Letters|August 7, 2012
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancerHideki Tomimoto, Masaki Hanibuchi, Fumitaka Ogushi, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Thoracic Cancer|September 5, 2023
Pretreatment eosinophil counts as a predictive biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.
Thoracic Cancer|December 17, 2024
Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case ReportYugo Matsumura, Seiya Ichihara, Kaori Nii, et al.
Thoracic Cancer|December 13, 2023
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitorsEiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2022
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancerEiji Takeuchi, Kensuke Kondo, Yoshio Okano, et al.
Circulation|January 29, 2014
Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer?Soji Nishio, Shinsaku Takeda, Kunihiko Kosuga, et al.
Circulation|January 21, 2015
Rare case of cardiac hemangioma causing massive pericardial effusion: can a left atrial tumor produce pericardial effusion?Soji Nishio, Kunihiko Kosuga, Senri Miwa, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 14, 2006
Histopathological findings of new in-stent lesions developed beyond five yearsKatsuyuki Hasegawa, Hideo Tamai, Eisho Kyo, et al.
Thoracic Cancer|September 17, 2023
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancerYohei Yabuki, Masaki Hanibuchi, Eiji Takeuchi, et al.
Modern Rheumatology|June 7, 2012
Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumabMie Fusama, Hideko Nakahara, Yoshimasa Hamano, et al.
Oncology Letters|August 7, 2012
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancerHideki Tomimoto, Masaki Hanibuchi, Fumitaka Ogushi, et al.
Pageof 10